EF
IART icon

Empowered Funds’s Integra LifeSciences IART Stock Holding History

Empowered Funds’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307K Buy
17,116
+6,045
+55% +$84.5K ﹤0.01% 1857
2026
Q1 		$104K Buy
+11,071
New +$122K ﹤0.01% 2069
2025
Q4 		– Sell
-11,213
Closed -$161K – 1425
2025
Q3 		$161K Sell
11,213
-86
-0.8% -$1.18K ﹤0.01% 1748
2025
Q2 		$139K Buy
+11,299
New +$164K ﹤0.01% 1690
2025
Q1 		– Sell
-7,923
Closed -$180K – 1697
2024
Q4 		$180K Buy
+7,923
New +$173K ﹤0.01% 1517

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Empowered Funds's IART Position: Q2 2026 in Review

Empowered Funds increased its Integra LifeSciences (IART) stake by 55% in Q2 2026, buying an estimated $84.5K and bringing the position to 17,116 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #1857.

Empowered Funds first reported a position in IART in Q4 2024 and has held it in 5 quarters since. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Empowered Funds held 17,116 shares of Integra LifeSciences worth $307K as of Q2 2026.
  • Empowered Funds bought 6,045 Integra LifeSciences shares in Q2 2026, an estimated $84.5K.
  • Integra LifeSciences made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1857 holding.
  • Empowered Funds first reported a position in Integra LifeSciences in Q4 2024 and has held it in 5 quarters since.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.